Methazolamide NDC 42571-240

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-240Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0240Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42571-240-05	42571024005	500 TABLET in 1 BOTTLE (42571-240-05)Marketed from Mar 5, 2019
42571-240-10	42571024010	1000 TABLET in 1 BOTTLE (42571-240-10)Marketed from Mar 5, 2019
42571-240-90	42571024090	90 TABLET in 1 BOTTLE (42571-240-90)Marketed from Mar 5, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methazolamide
Generic name (nonproprietary): methazolamide
Active ingredients: Methazolamide — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Micro Labs Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207438
Marketing start: Mar 5, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 42571-240_9ebf7533-27e6-54c2-e053-2995a90ae560SPL ID 9ebf7533-27e6-54c2-e053-2995a90ae560SPL set ID 91a493f5-f8c3-4b64-a15e-b550d8631668RxCUI 197939, 197940UNII W733B0S9SDUPC 0342571239909, 0342571240905

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442571024005 followed by a unit qualifier and the quantity

Package 42571-0240-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 17, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methazolamide tablets are indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207438

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207438
Product	Strength	Form · route	Labeler	Product NDC
Methazolamide	Methazolamide 50 mg/1	TabletOral	Bausch & Lomb Incorporated	24208-023
Methazolamide	Methazolamide 25 mg/1	TabletOral	Bausch & Lomb Incorporated	24208-022
Methazolamide	Methazolamide 25 mg/1	TabletOral	Micro Labs Limited	42571-239